Yazid Belkacémi
- Cancer Research top 1%
- Breast Cancer Treatment Studies 71
-
- Breast Lesions and Carcinomas 25
- Radiation top 1%
- Advanced Radiotherapy Techniques 23
- Oncology top 2%
- HER2/EGFR in Cancer Research 20
- Cancer Treatment and Pharmacology 17
- Dermatology top 1%
-
- Effects of Radiation Exposure 24
-
- Hematopoietic Stem Cell Transplantation 15
-
- Prostate Cancer Treatment and Research 14
- Co-authors
- D. AzriaMahmut ÖzsahinE. TouboulMichel SchliengerPhilip PoortmansA LaugierLuciano ScandolaroFrançoise Pène
- Partner nations
- FranceSwitzerlandUnited States
In The Last Decade
Yazid Belkacémi
195 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 1.4k
- Pathology and Forensic Medicine 1.1k
- Radiation 479
- Oncology 1.3k
- Dermatology 389
Countries citing papers authored by Yazid Belkacémi
This map shows the geographic impact of Yazid Belkacémi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yazid Belkacémi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yazid Belkacémi more than expected).
Fields of papers citing papers by Yazid Belkacémi
This network shows the impact of papers produced by Yazid Belkacémi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yazid Belkacémi. The network helps show where Yazid Belkacémi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yazid Belkacémi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 16 | |
| 9 | 2018 | 52 | |
| 10 | 2018 | 14 | |
| 11 | 2017 | 4 | |
| 12 | 2016 | 90 | |
| 13 | 2014 | 17 | |
| 14 | 2012 | 37 | |
| 15 | 2008 | 87 | |
| 16 | Apport de la tomographie par émission de positons en radiothérapie | 2007 | 3 |
| 17 | [HER-2/neu positive breast cancer: how to prescribe adjuvant trastuzumab (Herceptin)?]. | 2006 | 3 |
| 18 | 1998 | 24 | |
| 19 | 1996 | 20 | |
| 20 | 1994 | 57 |
About Yazid Belkacémi
Yazid Belkacémi is a scholar working on Cancer Research, Oncology and Radiation, having authored 212 papers that have together received 4.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (71 papers), Breast Lesions and Carcinomas (25 papers), Effects of Radiation Exposure (24 papers), Advanced Radiotherapy Techniques (23 papers), HER2/EGFR in Cancer Research (20 papers), Cancer Treatment and Pharmacology (17 papers), Hematopoietic Stem Cell Transplantation (15 papers) and Prostate Cancer Treatment and Research (14 papers). The work is most often cited by research in Cancer Research (1.4k citations), Pathology and Forensic Medicine (1.1k citations) and Radiation (479 citations). Yazid Belkacémi has collaborated with scholars based in France, Switzerland and United States. Frequent co-authors include D. Azria, Mahmut Özsahin, E. Touboul, Michel Schlienger, Philip Poortmans, A Laugier, Luciano Scandolaro, Françoise Pène, Joseph Gligorov and H. Marsiglia. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.